Table 1 Baseline characteristics of the study population [\(\overline{X}\) ± S or M(P25, P75), case(%)]
Variable | HFrEF | HFmrEF | HFpEF | χ2, F or H | P |
|---|---|---|---|---|---|
n | 15 | 15 | 66 | ||
Age (years) | 69.13 ± 6.79a | 71.07 ± 6.11 | 74.29 ± 6.16 | 4.982 | 0.009 |
BMI (kg/m2) | 22.06 (20.76,27.14) | 24.91 (21.05,28.34) | 24.91 (22.72,27.55) | 3.213 | 0.201 |
Women | 7 (46.7) | 4 (26.7) | 34 (51.5) | 3.031 | 0.220 |
Angina | 6 (40.0) | 3 (20.0) | 21 (31.8) | 1.403 | 0.499∆ |
dyspnea | 13 (86.7) | 13 (86.7) | 41 (62.1) | 5.562 | 0.054∆ |
syncope | 0 (0.0) | 1 (6.7) | 8 (12.1) | 1.637 | 0.568∆ |
NYHA class | a | 17.259 | 0.001∆ | ||
II | 0 (0.0) | 0 (0.0) | 5 (7.6) | ||
III | 3 (20.0) | 8 (53.3) | 46 (69.7) | ||
IV | 12 (80.0) | 7 (46.7) | 15 (22.7) | ||
smoking | 5 (33.3) | 5 (33.3) | 15 (22.7) | 1.449 | 0.526∆ |
Hypertension | 7 (46.7) | 11 (73.3) | 41 (62.1) | 2.291 | 0.318 |
Diabetes | 2 (13.3) | 6 (40.0) | 16 (24.2) | 2.754 | 0.278∆ |
Dyslipidemia | 5 (33.3) | 5 (33.3) | 27 (40.9) | 0.500 | 0.779 |
CHD | 11 (73.3) | 6 (40.0) | 37 (56.1) | 3.389 | 0.184 |
CKD | 1 (6.7) | 2 (13.3) | 2 (3.0) | 3.091 | 0.174∆ |
Prior MI | 3 (20.0) | 1 (6.7) | 8 (12.1) | 1.246 | 0.636∆ |
stroke | 1 (6.7) | 1 (6.7) | 9 (13.6) | 0.579 | 0.697∆ |
AF | 1 (6.7) | 4 (26.7) | 11 (16.7) | 2.041 | 0.338∆ |
CABG | 0 (0.0) | 0 (0.0) | 2 (3.0) | 0.576 | 1.000∆ |
PCI | 2 (13.3) | 1 (6.7) | 12 (18.2) | 0.987 | 0.755∆ |
heart rate (bpm) | 87.00 (73.00, 95.00) | 71.00 (62.00, 84.00) | 71.50 (63.00, 82.00) | 5.902 | 0.052 |
hsTnI (pg/ml) | 63.50 (39.40,852.94)a | 121.60 (43.00,166.40)a | 23.40 (10.93,69.68) | 17.615 | 0.000 |
BNP (pg/ml) | 2880.85 (1275.48,4290.55)a | 1487.91 (824.85,2370.30)a | 432.17 (169.15,1071.94) | 30.842 | 0.000 |
uric acid (umol/L) | 512.00 (415.00, 639.00)a | 448.00 (348.00, 559.00) | 405.00 (282.00, 468.00) | 10.326 | 0.006 |